Changes in non-transferrin-bound iron (NTBI) in pregnant women on iron supplements

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 140, Issue 2, 2008, Pages 281-282

  Baron, Joel ^a   Ben David, Gila ^a   Hallak, Mordechai ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC HYDROXIDE SUCROSE; FERROUS CALCIUM CITRATE; IRON; IRON DERIVATIVE; NON TRANSFERRIN BOUND IRON; UNCLASSIFIED DRUG;

BLOOD SAMPLING; DISEASE SEVERITY; FEMALE; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; LETTER; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 52949139445     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.01.002     Document Type: Letter

References (4)

1. Breuer W., and Cabntchik Z.I. A fluorescence based one step assay for serum non-transferrin-bound iron. Anal Biochem 299 (2001) 194-202
2. Breuer W., Hershko C., and Cabantchik Z.I. The importance of non-transferrin-bound iron in disorders of iron metabolism. Trans Sci 23 (2000) 185-192
3. Cunningham FG, Leveno JK, Bloom SL, Hauth JC, Gilstrap LC, Wendstrom KD. Williams Manual of Obstetrics. 22nd edition. Columbus, OH: McGraw-Hill Companies.
4. Casanueva E., and Fernando E.V. Iron and oxidative stress in pregnancy. J Nutr 133 (2003) 1700-1708